AML |
acute myelogenous leukemia |
ASM |
aggressive systemic mastocytosis |
CTLA-4 |
cytotoxic T lymphocyte-associated antigen-4 |
DC |
dendritic cell |
DNA-PKcs |
DNA-dependent protein kinase, catalytic subunit |
FcεRIγ |
Fc receptor γ chain |
FGF |
fibroblast growth factor |
Gab |
Grb2-associated binder family member (Gab) |
GIST |
gastrointestinal stromal tumor |
GM-CSF |
granulocyte macrophage colony-stimulating factor |
GrB |
granzyme B |
HLA |
human leukocyte antigen |
IFN |
interferon |
IL |
interleukin |
ILT |
immunoglobulin-like transcript |
ISM |
indolent systemic mastocytosis |
ITAM |
immunoreceptor tyrosine-based activation motifs |
ITIM |
immunoreceptor tyrosine-based inhibitory motif |
JAK |
Janus kinase |
JNK |
c-Jun N-terminal kinase |
KIR |
killer immunoglobulin-like receptor |
LAG-3 |
lymphocyte activation gene-3 |
LIF |
leukemia growth factor |
MAPK |
mitogen-activated protein kinase |
MCL |
mast cell leukemia |
MDSC |
myeloid derived suppressive cell |
MHC |
major histocompatibility |
MMP |
matrix metalloprotease |
NK |
natural killer |
NGF |
nerve growth factor |
PB-mast |
human cultured mast cells established from peripheral blood derived from healthy volunteers |
PD |
programmed death |
PI3K |
phosphatidylinositol 3-kinase |
PlGF |
placental growth factor |
PTdNK |
pregnancy trained decidual NK cell |
SCF |
stem cell factor |
sFlt-1 |
soluble fms-like tyrosine kinase-1 |
SHIP |
Src homology 2 domain-containing inositol 5-phosphatase |
SHP |
Src homology 2 domain-containing tyrosine phosphatase |
SM-AHNMD |
systemic mastocytosis with an associated clonal hematologic non-MC-lineage disease |
STAT |
signal transducer and activator of transcription |
TGF |
transforming growth factor |
TIGIT |
T cell immunoglobulin ITIM domain |
TIM-3 |
T cell immunoglobulin and mucin-domain containing-3 |
TKD |
tyrosine-kinase domain |
TNF |
tumor necrosis factor |
Treg |
regulatory T cell |
VEGF |
vascular endothelial growth factor |
VISTA |
V-domain Ig suppressor of T cell activation |